Streamlined Process
- Standardization of CT, MR and DXA image acquisition protocols across global sites
- Imaging Review Charter
- 24/7 global site management
- Rigorous quality control and validation process
- Abide by Metrics Champion Consortium (MCC)
Interested in our specialized
NASH imaging capabilities?
Integrated Technology
- Validated analytical workstations dedicated to CT/MR/DXA data analysis
- Seamless integration with other study-related services such as IVRS (ClinTrak®)
- Cloud-based image transmission system with zero local IT footprint (ClinTrak Imaging)
Endocrine and Metabolic Imaging Experience
Modalities
- Computed Tomography (CT)
- Magnetic Resonance Elastography (MRE)
- Magnetic Resonance Imaging (MRI)
- Dual-Energy X-Ray Absorptiometry (DXA)
- Cardiac Safety/TQT
- Ambulatory Blood Pressure
Sample Specialties
- Lipids
- Nonalcoholic Steatohepatitis (NASH)
- Rare Endocrine Disorders
- Diabetes
- Obesity
- Chronic Kidney Disease
- Acromegaly
Response Criteria
Medpace core labs provide imaging analysis for metabolic disorders such as diabetes, obesity, non-alcoholic fatty liver non-alcoholic Steatohepatitis (NASH). Our metabolic imaging endpoint measurements include hepatic fat fraction, and hepatic fibrosis. Our cardiac safety solutions for metabolic disorders include TQT Studies, ambulatory ECG monitoring and ambulatory blood pressure monitoring.
Resources
At-A-Glance: Core Labs
Expert Insights: Q&A with Dr. Mustafa Bashir, NASH Imaging Expert
Deep Dive: Metabolic and Endocrine Rare Disease
Fact Sheet: Metabolic and Endocrine
Webinar: Navigating the Complexities of NASH Development: Valuable Insights from a Key Opinion Leader
